Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,450 total articles

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

Intelligent Bio Solutions Inc. (Nasdaq: INBS) has entered a securities purchase agreement with a single institutional investor for a private placement priced at-the-market under Nasdaq rules. The offering includes common stock and warrants totaling expected gross proceeds of about $5 million before fees. The proceeds will be used for working capita…

SAB BIO to Participate in Upcoming Investor Conferences

SAB BIO to Participate in Upcoming Investor Conferences

SAB Biotherapeutics, a clinical-stage biopharmaceutical company developing human immunoglobulin therapies for autoimmune diseases including type 1 diabetes, announced that its management team will participate in prominent investor conferences in September 2026. The company focuses on novel therapeutic candidates derived from engineered transchromos…

Leonardo DRS Selected by United States Space Force to Advance Technology in support of advanced Space Superiority Solutions

Leonardo DRS Selected by United States Space Force to Advance Technology in support of advanced Space Superiority Solutions

Leonardo DRS, a Nasdaq-listed defense technology company, has been awarded a Prototype contract by the U.S. Space Force to advance next-generation affordable and scalable sensor technologies tailored for space superiority and control missions. The contract emphasizes innovation in sensing and processing capabilities with enhanced manufacturability …

Conexeu Sciences Sets September and October 2026 Conference Schedule

Conexeu Sciences Sets September and October 2026 Conference Schedule

Conexeu Sciences Inc., a preclinical-stage biotechnology company focused on regenerative tissue restoration, will participate in several investor and industry conferences in September and October 2026. The company plans to engage stakeholders while advancing its CXU™ extracellular matrix platform, targeting multiple large markets including wound ca…

Alpha Compute Supports the 9/11 & Freedom 250 Gala in New York City

Alpha Compute Supports the 9/11 & Freedom 250 Gala in New York City

Alpha Compute Corp., a Nasdaq-listed AI infrastructure company, announced its sponsorship of the 9/11 & Freedom 250 Gala in New York City, commemorating the 25th anniversary of the September 11 terrorist attacks and the USA's 250th anniversary. The gala supports organizations benefiting veterans, community, and education. CEO Brittany Kaiser will a…

Biomerica Reports Fiscal 2026 Year-End Financial Results

Biomerica Reports Fiscal 2026 Year-End Financial Results

Biomerica, Inc. reported its fiscal year 2026 financial results, showing a 17% increase in Q4 net sales, a 24% improvement in full-year net loss, and key commercial advancements including Medicare reimbursement for its inFoods IBS test. The company completed a $2.23 million financing to support ongoing commercialization and strategic initiatives.

Navitas Delivers Latest Gen 5 GaNFast™ Manufactured in the U.S. Through GlobalFoundries Partnership to Accelerate AI Infrastructure

Navitas Delivers Latest Gen 5 GaNFast™ Manufactured in the U.S. Through GlobalFoundries Partnership to Accelerate AI Infrastructure

Navitas Semiconductor announces the first shipments of its 5th Generation GaNFast™ GaN power semiconductors manufactured domestically at GlobalFoundries' U.S.-based 200mm GaN-on-Si facility. This collaboration strengthens U.S. semiconductor supply chains for critical AI infrastructure, high-performance computing, industrial electrification, and nat…

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

VivoSim Labs announces development of a rat liver model to complement its existing human liver NAMkind™ platform, aiming to improve drug toxicity testing by differentiating species-specific toxicological effects. This bi-species comparative model is designed to help pharmaceutical companies better assess drug safety and reduce premature termination…

Wetour Robotics Demonstrates sEMG-Vision System Targeting Force and Occlusion Blind Spots in Physical AI Training

Wetour Robotics Demonstrates sEMG-Vision System Targeting Force and Occlusion Blind Spots in Physical AI Training

Wetour Robotics Limited has demonstrated its Orchestra system, integrating surface electromyography (sEMG) wristband data with first-person vision to overcome limitations of vision-only robot training. The fusion of muscle activation data with visual input enables more accurate capture of hand movement and force, even during occlusions, improving d…

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter

22nd Century Group, a Nasdaq-listed leader in low-nicotine tobacco products, reports accelerating growth with expanded retail presence from 2,000 to an expected 5,000 outlets by year-end 2026, improved gross margins driven by branded products, and consistent monthly sales growth. The company remains focused on commercial execution and innovation, l…

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Daxor Corporation, a Nasdaq-listed medical diagnostics company specializing in precise blood volume measurement technology, delivered a mid-year corporate update highlighting its financial strength, commercial expansion with new sales leadership, manufacturing capacity investments, and ongoing clinical validation supporting its innovative next-gene…

Rezolve Ai Reports $130.8 Million H1 Revenue, Up Nearly 21-Fold, as Google Validates Its Infrastructure Strategy for the Agentic Economy

Rezolve Ai Reports $130.8 Million H1 Revenue, Up Nearly 21-Fold, as Google Validates Its Infrastructure Strategy for the Agentic Economy

Rezolve Ai PLC reported an extraordinary 1,970% revenue increase to $130.8 million in H1 2026, driven by expanded customer base and robust partner-led distribution with Microsoft, Google, TCS, and Tech Mahindra. The company’s proprietary AI commerce infrastructure technology received critical validation through Google's infrastructure-level deploym…

Voyager to Present at Upcoming Investor Conferences

Voyager to Present at Upcoming Investor Conferences

Voyager Therapeutics, a biotechnology company focused on genetic treatments for neurological disorders, announced participation in several upcoming investor conferences including Wells Fargo, Cantor, Morgan Stanley, Baird, and H.C. Wainwright. The company will hold multiple fireside chats to discuss its pipeline and partnerships, with a webcast ava…